论文部分内容阅读
随着输血技术的发展及成分输血的出现,资源匮乏的血液得到充分利用同时也减少了输血不良反应的发生,成分输血在我国得到全面推广。血小板是血液凝固中的重要成分,血小板输注是防止大出血和提高血小板减少患者生存率的主要措施,目前多用于外伤大出血患者及血液和肿瘤患者。但是反复输注血小板会刺激免疫系统产生血小板特异性抗体或血小板表面相关抗体,导致输注的血小
With the development of blood transfusion technology and the emergence of transfusion of blood components, the scarce blood is fully utilized and the adverse reactions of transfusion are also reduced. The transfusion of components has been fully promoted in China. Platelet is an important component of blood coagulation, platelet transfusion is to prevent bleeding and improve survival in patients with thrombocytopenia, the main measure, is currently used in patients with traumatic hemorrhage and blood and cancer patients. However, repeated infusion of platelets stimulates the immune system to produce platelet-specific antibodies or platelet-associated antibodies, resulting in transfusion of small blood